Novavax

Yahoo Finance • 4 months ago

Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?

It's been a great year for Novavax(NASDAQ: NVAX). The biotech is up by 150% since January. However, analysts see even more upside for the vaccine maker. The consensus estimate of $20 a share implies a 65% increase over its current stock pr... Full story

Yahoo Finance • 6 months ago

Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake

Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the company's share price 50% of the business is held by the top 13 shareholders Insiders have been selling lately Every investo... Full story

Yahoo Finance • 7 months ago

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 v... Full story

Yahoo Finance • 7 months ago

3 Things You Need to Know If You Buy Novavax Today

Novavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the coronavirus vaccine race, sending the stock to a 2,700% gain back in 2020. But when N... Full story

Yahoo Finance • 7 months ago

Could Novavax Become the Next Moderna?

Novavax(NASDAQ: NVAX) and Moderna(NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% in... Full story

Yahoo Finance • 7 months ago

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

Despite some turbulence, growth stocks have been on a bull run since the 2008 financial crisis. Groundbreaking innovations in technology and healthcare have been the primary drivers behind this trend. Which growth stocks stand out as top... Full story

Yahoo Finance • 7 months ago

Novavax Stock Just Tripled. Is It Too Late to Buy?

After losing more than 90% of its value from a peak back in 2021, Novavax(NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing deal with French pharmac... Full story

Yahoo Finance • 7 months ago

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED) Editor’s note: This story has been updated to correct an error in the price a... Full story

Yahoo Finance • 7 months ago

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts

Since the page turned to 2023 a little over 16 months ago, the bulls have been running wild on Wall Street. Professional and everyday investors have flocked to high-growth, innovation-driven businesses, and have been particularly enamored... Full story

Yahoo Finance • 10 months ago

Earnings Update: Novavax, Inc. (NASDAQ:NVAX) Just Reported And Analysts Are Trimming Their Forecasts

Novavax, Inc. (NASDAQ:NVAX) missed earnings with its latest full-year results, disappointing overly-optimistic forecasters. Revenues missed expectations somewhat, coming in at US$984m, but statutory earnings fell catastrophically short, wi... Full story

Yahoo Finance • 11 months ago

Novavax, Inc. (NASDAQ:NVAX): Is Breakeven Near?

We feel now is a pretty good time to analyse Novavax, Inc.'s (NASDAQ:NVAX) business as it appears the company may be on the cusp of a considerable accomplishment. Novavax, Inc., a biotechnology company, that promotes improved health by dis... Full story

Yahoo Finance • 11 months ago

3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market

The S&P 500 last month reached a new record high, officially confirming that we are in a bull market. This environment may feel new, but the index actually has been in bull territory ever since it started to rebound from bear market lows 1... Full story

Yahoo Finance • 11 months ago

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts

Over the long run, Wall Street has proved to be a surefire wealth creator. But over shorter periods, the performance of the major stock indexes is unpredictable. Since this decade began, the Dow Jones Industrial Average, S&P 500, and Nasda... Full story

Yahoo Finance • 11 months ago

Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?

Novavax(NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as quickly as planned. Novavax's product launched... Full story

Yahoo Finance • 11 months ago

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

For optimists, 2023 was a stellar year. The ageless Dow Jones Industrial Average climbed to a fresh all-time high, while the S&P 500 and Nasdaq Composite logged respective gains of 24% and 43% by the time the curtain closed. But just beca... Full story

Yahoo Finance • 12 months ago

Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th Annual J.P. Morgan Healthcare... Full story

Yahoo Finance • 12 months ago

7 Magnificent Stocks That Can Double Your Money in 2024

What a difference a year can make on Wall Street. After enduring two bear markets in less than three years, all three major indexes soared in 2023. The iconic Dow Jones Industrial Average climbed to a record high, while the broad-based S&P... Full story

Yahoo Finance • last year

Canadians Can Help Protect Loved Ones as We Head into the Holiday Season

Novavax launches Choose to Protect™ campaign to educate public about importance of updated COVID-19 vaccination Recent survey finds that 70% of Canadians believe in the value of COVID-19 vaccination; 74% want to select the COVID-19 vaccine... Full story

Yahoo Finance • last year

Novavax's Updated COVID-19 Vaccine Now Authorized in Canada

Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md., Dec. 5, 2023 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing p... Full story

Yahoo Finance • last year

Is Novavax Stock a Buy Now?

Biotech company Novavax (NASDAQ: NVAX) went from being relatively unknown just four years ago to becoming one of the U.S. COVID-19 vaccine market leaders. The company has faced many trials and tribulations in this period, however. If Novav... Full story